21/17157 - Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season
Open tender contest
Pursuant to parts I and III of the Norwegian Regulations relating to public procurement (Forskrift om offentlige anskaffelser, FOA) for the procurement of
Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season
The Norwegian Institute of Public Health (NIPH) is carrying out procurement of an enhanced quadrivalent vaccine against seasonal influenza for vaccination of people aged 65 or older in nursing homes. Enhanced influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups included in the national immunisation scheme.
The procurement is held as an open tender contest and will be carried out using the electronic competition administration tool (KGV), CTM (EU-Supply).
Toghether with information and requirements given in the ectronic competition administration tool, the Call for Tender stipulates the regulations and conditions for the procurement process.